Identification of TNFRSF12A as a key regulator of stemness and immunosuppression in a novel glioma subtype via multi-omics analysis and experimental validation
Shengyu Sun, Bo Zhang, Pengfei Chen, Liang Wu, Zhanfeng Niu. Identification of TNFRSF12A as a key regulator of stemness and immunosuppression in a novel glioma subtype via multi-omics analysis and experimental validation. // Clinical Immunology. – DOI: 10.1016/j.clim.2026.110755. – URL: https://www.sciencedirect.com/science/article/pii/S1521661626000938?dgcid=rss_sd_all
Shengyu Sun, Bo Zhang, Pengfei Chen, Liang Wu, & Zhanfeng Niu Identification of TNFRSF12A as a key regulator of stemness and immunosuppression in a novel glioma subtype via multi-omics analysis and experimental validation. Clinical Immunology. https://doi.org/10.1016/j.clim.2026.110755
Shengyu Sun, et al. “Identification of TNFRSF12A as a key regulator of stemness and immunosuppression in a novel glioma subtype via multi-omics analysis and experimental validation.” Clinical Immunology. doi:10.1016/j.clim.2026.110755.
@article{Sun,
title = {Identification of TNFRSF12A as a key regulator of stemness and immunosuppression in a novel glioma subtype via multi-omics analysis and experimental validation},
author = {Sun, Shengyu and Zhang, Bo and Chen, Pengfei and Wu, Liang and Niu, Zhanfeng},
journal = {Clinical Immunology},
doi = {10.1016/j.clim.2026.110755},
url = {https://www.sciencedirect.com/science/article/pii/S1521661626000938?dgcid=rss_sd_all}
}